{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T20:05:32Z","timestamp":1779912332480,"version":"3.53.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,3,22]],"date-time":"2019-03-22T00:00:00Z","timestamp":1553212800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Gastroenterol"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s12664-019-00934-x","type":"journal-article","created":{"date-parts":[[2019,3,22]],"date-time":"2019-03-22T13:02:51Z","timestamp":1553259771000},"page":"110-116","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Genotype distribution in relation to viral load in a large cohort of Indian patients with chronic hepatitis C virus infection: A retrospective analysis"],"prefix":"10.1007","volume":"38","author":[{"given":"Balkumar Reddy","family":"Panyala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rathindra Mohan","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Himaja","family":"Devarakonda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sivasathish","family":"Tadivaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagaraja Rao","family":"Padaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mithun","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nageshwar Reddy","family":"Duvvuru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,22]]},"reference":[{"key":"934_CR1","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1056\/NEJM200107053450107","volume":"345","author":"GM Lauer","year":"2001","unstructured":"Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med. 2001;345:41\u201352.","journal-title":"N Engl J Med"},{"key":"934_CR2","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1111\/jvh.12123","volume":"20","author":"GS Cooke","year":"2013","unstructured":"Cooke GS, Lemoine M, Thursz M, et al. Viral hepatitis and the global burden of disease: a need to regroup. J Viral Hepat. 2013;20:600\u20131.","journal-title":"J Viral Hepat"},{"key":"934_CR3","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1002\/hep.26141","volume":"57","author":"HK Mohd","year":"2013","unstructured":"Mohd HK, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: new estimates of age specifc antibody to HCV seroprevalence. Hepatology. 2013;57:1333\u201342.","journal-title":"Hepatology"},{"key":"934_CR4","first-page":"219","volume":"83","author":"MN Khaja","year":"2002","unstructured":"Khaja MN, Munpally SK, Hussain MM, Habeebullah CM. Hepatitis C virus: the Indian scenario. Curr Sci. 2002;83:219\u201324.","journal-title":"Curr Sci"},{"key":"934_CR5","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3109\/10408410903357455","volume":"36","author":"N Bostan","year":"2010","unstructured":"Bostan N, Mahmood T. An overview about hepatitis C: a devastating virus. Crit Rev Microbiol. 2010;36:91\u2013133.","journal-title":"Crit Rev Microbiol"},{"key":"934_CR6","doi-asserted-by":"publisher","first-page":"4808","DOI":"10.3748\/wjg.v13.i36.4808","volume":"13","author":"J Timm","year":"2007","unstructured":"Timm J, Roggendorf M. Sequence diversity of hepatitis C virus: implications for immune control and therapy. World J Gastroenterol. 2007;13:4808\u201317.","journal-title":"World J Gastroenterol"},{"key":"934_CR7","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/hep.27259","volume":"61","author":"PM Jane","year":"2015","unstructured":"Jane PM, Isla H, Abraham F, et al. Global distribution and prevalence of hepatitis C virus genotypes. Hepatology. 2015;61:77\u201387.","journal-title":"Hepatology"},{"key":"934_CR8","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1056\/NEJMoa1214854","volume":"368","author":"IM Jacobson","year":"2013","unstructured":"Jacobson IM, Gordon C, Kowdley KV, et al. Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment options. N Engl J Med. 2013;368:1867\u201377.","journal-title":"N Engl J Med"},{"key":"934_CR9","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1056\/NEJMoa1214853","volume":"368","author":"E Lawitz","year":"2013","unstructured":"Lawitz E, Mangia A, Wyles D, et al. Sofosbuvir for previously untreated chronic hepatitis C infection. N Engl J Med. 2013;368:1878\u201387.","journal-title":"N Engl J Med"},{"key":"934_CR10","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1016\/S0140-6736(15)60605-5","volume":"385","author":"H Wedemeyer","year":"2015","unstructured":"Wedemeyer H. Towards interferon-free treatment for all HCV genotypes. Lancet. 2015;385:2443\u20135.","journal-title":"Lancet"},{"key":"934_CR11","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/S1665-2681(19)31835-6","volume":"7","author":"BM Garcia-Montalvo","year":"2008","unstructured":"Garcia-Montalvo BM, Galguera-Colorado PL. Distribution of hepatitis C virus genotypes, risk factors and liver disease in patients from Yucatan, Mexico. Ann Hepatol. 2008;7:345\u20139.","journal-title":"Ann Hepatol"},{"key":"934_CR12","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.diagmicrobio.2008.03.011","volume":"61","author":"V Verma","year":"2008","unstructured":"Verma V, Chakravarti A, Kar P. Genotypic characterization of hepatitis C virus and its significance in patients with chronic liver disease from northern India. Diagn Microbiol Infect Dis. 2008;61:408\u201314.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"934_CR13","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1111\/j.1365-3148.2006.00704.x","volume":"16","author":"A Chakravarti","year":"2006","unstructured":"Chakravarti A, Verma V. Distribution of hepatitis genotypes in \u03b2-thalassaemic patients from North India. Trans Med. 2006;16:433\u20138.","journal-title":"Trans Med"},{"key":"934_CR14","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1002\/(SICI)1096-9071(199602)48:2<191::AID-JMV12>3.0.CO;2-I","volume":"48","author":"AK Panigrahi","year":"1996","unstructured":"Panigrahi AK, Roca J, Acharya SK, Jameel S, Panda SK. Genotype determination of hepatitis C virus from northern India: identification of new subtypes. J Med Virol. 1996;48:191\u20138.","journal-title":"J Med Virol"},{"key":"934_CR15","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1099\/0022-1317-76-3-711","volume":"76","author":"T Valliammai","year":"1995","unstructured":"Valliammai T, Thyagarajan SP, Zuckerman AJ, Harrisomn TJ. Diversity of genotypes of hepatitis C virus in southern India. J Gen Virol. 1995;76:711\u20136.","journal-title":"J Gen Virol"},{"key":"934_CR16","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1053\/jhep.2003.50157","volume":"37","author":"A Chowdhury","year":"2003","unstructured":"Chowdhury A, Santra A, Chaudhuri S, et al. Hepatitis C virus in the general population: a community-based study in West Bengal, India. Hepatology. 2003;37:802\u20139.","journal-title":"Hepatology"},{"key":"934_CR17","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S1386-6532(02)00025-2","volume":"26","author":"S Raghuraman","year":"2003","unstructured":"Raghuraman S, Shaji RV, Sridharan G, et al. Distribution of the different genotypes of HCV among patients attending a tertiary care hospital in south India. J Clin Virol. 2003;26:61\u20139.","journal-title":"J Clin Virol"},{"key":"934_CR18","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1002\/hep.22759","volume":"49","author":"MG Ghany","year":"2009","unstructured":"Ghany MG, Strader DB, Thomas DL, Seeff LB, American Association for the Study of Liver Diseases. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology. 2009;49:1335\u201374.","journal-title":"Hepatology"},{"key":"934_CR19","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/S0140-6736(01)06102-5","volume":"358","author":"MP Manns","year":"2001","unstructured":"Manns MP, McHutchison JG, Gordon SC, et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet. 2001;358:958\u201365.","journal-title":"Lancet"},{"key":"934_CR20","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.jceh.2014.08.004","volume":"4","author":"V Gupta","year":"2014","unstructured":"Gupta V, Kumar A, Sharma P, et al. Sustained virological response rates to antiviral therapy in genotype 1 and 3 chronic hepatitis C patients: a study from north Inida. J Clin Exp Hepatol. 2014;4:287\u201392.","journal-title":"J Clin Exp Hepatol"},{"key":"934_CR21","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.jceh.2014.05.006","volume":"4","author":"P Puri","year":"2014","unstructured":"Puri P, Anand AC, Saraswat VA, et al. Consensus statement of HCV task force of the Indian National Association for the Study of the Liver (INASL). Part I: status report of HCV infection in India. J Clin Exp Hepatol. 2014;4:106\u201316.","journal-title":"J Clin Exp Hepatol"},{"key":"934_CR22","doi-asserted-by":"publisher","first-page":"497","DOI":"10.2147\/DDDT.S130945","volume":"11","author":"F Mir","year":"2017","unstructured":"Mir F, Kahveci AS, Ibdah JA, Tahan V. Sofosbuvir\/velpatasvir regimen promises an effective pan-genotypic hepatitis C virus cure. Drug Des Devel Ther. 2017;11:497\u2013502.","journal-title":"Drug Des Devel Ther"},{"key":"934_CR23","doi-asserted-by":"publisher","first-page":"349","DOI":"10.4103\/0255-0857.118875","volume":"31","author":"J Christdas","year":"2013","unstructured":"Christdas J, Sivakumar J, David J, Daniel HD, Raghuraman S, Abraham P. Genotypes of hepatitis C virus in the Indian sub-continent: a decade long experience from a tertiary care hospital in South India. Indian J Med Microbiol. 2013;31:349\u201353.","journal-title":"Indian J Med Microbiol"},{"key":"934_CR24","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1053\/jhep.2003.50157","volume":"37","author":"A Chowdhury","year":"2003","unstructured":"Chowdhury A, Santra A, Chaudhuri S, et al. Hepatitis C virus infection in the general population: a community-based study in West Bengal, India. Hepatology. 2003;37:802\u20139.","journal-title":"Hepatology"},{"key":"934_CR25","doi-asserted-by":"publisher","first-page":"905","DOI":"10.18203\/2349-3933.ijam20163721","volume":"3","author":"JP Kumar","year":"2016","unstructured":"Kumar JP, Puttamaregowda H. Distribution of hepatitis C virus genotypes in patients with chronic hepatitis C infection in Karnataka, South India. Int J Adv Med. 2016;3:905\u20137.","journal-title":"Int J Adv Med"},{"key":"934_CR26","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1093\/infdis\/169.6.1219","volume":"169","author":"D Gretch","year":"1994","unstructured":"Gretch D, Corey L, Wilson J, et al. Assessment of hepatitis C virus RNA levels by quantitative competitive RNA polymerase chain reaction: high titer viraemia correlates with advanced stage of disease. J Infect Dis. 1994;169:1219\u201325.","journal-title":"J Infect Dis"},{"key":"934_CR27","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1002\/hep.1840170404","volume":"17","author":"H Hagiwara","year":"1993","unstructured":"Hagiwara H, Hayashi N, Mita E, et al. Quantitation of hepatitis C virus RNA in serum of asymptomatic blood donors and patients with type C chronic liver disease. Hepatology. 1993;17:545\u201350.","journal-title":"Hepatology"},{"key":"934_CR28","first-page":"326","volume":"133","author":"A Chakravarti","year":"2011","unstructured":"Chakravarti A, Dogra G, Verma V, Srivastava AP. Distribution pattern of HCV genotypes and its association with viral load. Indian J Med Res. 2011;133:326\u201331.","journal-title":"Indian J Med Res"},{"key":"934_CR29","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/hep.27095","volume":"60","author":"F Kanwal","year":"2014","unstructured":"Kanwal F, Kramer JR, Ilyas J, Duan Z, El-Sarang HB. HCV genotype 3 is associated with an increased risk of cirrhosis and hepatocellular cancer in a national sample of U. S Veterans with HCV. Hepatology. 2014;60:98\u2013105.","journal-title":"Hepatology"},{"key":"934_CR30","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.cgh.2016.10.012","volume":"15","author":"BJ McMahon","year":"2017","unstructured":"McMahon BJ, Bruden D, Townshend-Bulson L, et al. Infection with hepatitis C virus genotype 3 is an independent risk factor for end-stage liver disease, hepatocellular carcinoma and liver-related death. Clin Gastroenterol Hepatol. 2017;15:431\u20137.","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Indian Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12664-019-00934-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12664-019-00934-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12664-019-00934-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,21]],"date-time":"2020-03-21T00:30:27Z","timestamp":1584750627000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12664-019-00934-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,22]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["934"],"URL":"https:\/\/doi.org\/10.1007\/s12664-019-00934-x","relation":{},"ISSN":["0254-8860","0975-0711"],"issn-type":[{"value":"0254-8860","type":"print"},{"value":"0975-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,22]]},"assertion":[{"value":"27 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"BRP, RMM, HD, ST, NRP, MS, and NRD declares that there are no conflicts of interest. The study protocol was approved by the Institutional Review Board.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The authors declare that the study was performed in a manner conforming to the Helsinki declaration of 1975, as revised in 2000 and 2008 concerning human and animal rights, and the authors followed the policy concerning informed consent as shown on Springer.com.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}},{"value":"The authors are solely responsible for the data and the content of the paper. In no way, the Honorary Editor-in-Chief, Editorial Board Members, or the printer\/publishers are responsible for the results\/findings and content of this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}}]}}